Mitesh

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the June and July 2025 reimbursement prices for the following products, to reflect an increase in their NHS list prices. To avoid pharmacy owners dispensing these products at a loss, DHSC has agreed [...]

The post Retrospective reimbursement prices for June and July 2025 appeared first on Community Pharmacy England.

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the June and July 2025 reimbursement prices for the following products, to reflect an increase in their NHS list prices. To avoid pharmacy owners dispensing these products at a loss, DHSC has agreed [...]

The post Retrospective reimbursement prices for June and July 2025 appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Levetiracetam 100mg/ml oral solution (Accord Healthcare Limited) Date issued: 14 August 2025 Drug Alert Number: EL(25)A/40 Accord Healthcare Limited, UK has informed the MHRA that the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SPC) do not contain all the required safety information. DMRC reference number: DMRC-35838218 Marketing Authorisation [...]

The post MHRA Class 4 Medicines Defect Notification: Levetiracetam 100mg/ml oral solution (Accord Healthcare Limited) appeared first on Community Pharmacy England.

Dapagliflozin 5mg and 10mg tablets will be moving from Category C to Category M in the September 2025 Drug Tariff. This comes after several manufacturers launched generic versions of Dapagliflozin tablets following the recent ruling by the UK Court of Appeal to invalidate AstraZeneca’s patent for the brand Forxiga®. Currently, all branded and generically written prescriptions [...]

The post Dapagliflozin tablets – changes to reimbursement from September 2025 appeared first on Community Pharmacy England.

The NHS Business Services Authority (NHSBSA) has seen an increase in the number of prescriptions from patients using the “HRT only prescription prepayment certificate” prescription charge exemption category for products that are not covered by the HRT Prescription Prepayment Certificate (HRT PPC). In the 12 months between June 2024 and May 2025, the NHSBSA received over 200k [...]

The post Medicines not covered by the HRT PPC appeared first on Community Pharmacy England.